Login / Signup
Yonathan Fuchs
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 7
Top Topics
Mesenchymal Stem Cells
Pseudomonas Aeruginosa
Ejection Fraction
Young Adults
Top Venues
Hepatology communications
Clinical liver disease
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yonathan Fuchs
,
Pamela L Valentino
Natural history and prognosis of pediatric PSC with updates on management.
Clinical liver disease
21 (2) (2023)
Steven Levitte
,
Yonathan Fuchs
,
Russell T Wise
,
Zachary M Sellers
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis.
Hepatology communications
7 (2) (2023)
Steven Levitte
,
Yonathan Fuchs
,
Russell T Wise
,
Zachary M Sellers
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis.
Hepatology communications
7 (2) (2023)
Steven Levitte
,
Yonathan Fuchs
,
Russell T Wise
,
Zachary M Sellers
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis.
Hepatology communications
7 (2) (2023)
Steven Levitte
,
Yonathan Fuchs
,
Russell T Wise
,
Zachary M Sellers
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis.
Hepatology communications
7 (2) (2023)
Yonathan Fuchs
,
Pamela L Valentino
Natural history and prognosis of pediatric PSC with updates on management.
Clinical liver disease
21 (2) (2023)
Steven Levitte
,
Yonathan Fuchs
,
Russell T Wise
,
Zachary M Sellers
Effects of CFTR modulators on serum biomarkers of liver fibrosis in children with cystic fibrosis.
Hepatology communications
7 (2) (2023)